Free Trial

SeaStar Medical (ICU) Competitors

SeaStar Medical logo
$3.03
-0.07 (-2.26%)
(As of 11/1/2024 ET)

ICU vs. EUCR, CLGN, APYX, CODX, ALUR, SURG, DRIO, STIM, FEMY, and OM

Should you be buying SeaStar Medical stock or one of its competitors? The main competitors of SeaStar Medical include Eucrates Biomedical Acquisition (EUCR), CollPlant Biotechnologies (CLGN), Apyx Medical (APYX), Co-Diagnostics (CODX), Allurion Technologies (ALUR), SurgePays (SURG), DarioHealth (DRIO), Neuronetics (STIM), Femasys (FEMY), and Outset Medical (OM).

SeaStar Medical vs.

SeaStar Medical (NASDAQ:ICU) and Eucrates Biomedical Acquisition (NASDAQ:EUCR) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, media sentiment, profitability, community ranking, dividends, valuation, institutional ownership and earnings.

SeaStar Medical's return on equity of 0.00% beat Eucrates Biomedical Acquisition's return on equity.

Company Net Margins Return on Equity Return on Assets
SeaStar MedicalN/A N/A -666.82%
Eucrates Biomedical Acquisition N/A -62.82%2.95%

1.7% of SeaStar Medical shares are held by institutional investors. Comparatively, 56.0% of Eucrates Biomedical Acquisition shares are held by institutional investors. 3.0% of SeaStar Medical shares are held by insiders. Comparatively, 19.5% of Eucrates Biomedical Acquisition shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

SeaStar Medical has a beta of -1.14, meaning that its share price is 214% less volatile than the S&P 500. Comparatively, Eucrates Biomedical Acquisition has a beta of -0.07, meaning that its share price is 107% less volatile than the S&P 500.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SeaStar Medical
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Eucrates Biomedical Acquisition
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SeaStar MedicalN/AN/A-$26.23M-$19.78-0.15
Eucrates Biomedical AcquisitionN/AN/A$2.42MN/AN/A

In the previous week, SeaStar Medical had 4 more articles in the media than Eucrates Biomedical Acquisition. MarketBeat recorded 4 mentions for SeaStar Medical and 0 mentions for Eucrates Biomedical Acquisition. SeaStar Medical's average media sentiment score of 0.00 equaled Eucrates Biomedical Acquisition'saverage media sentiment score.

Company Overall Sentiment
SeaStar Medical Neutral
Eucrates Biomedical Acquisition Neutral

SeaStar Medical received 1 more outperform votes than Eucrates Biomedical Acquisition when rated by MarketBeat users.

CompanyUnderperformOutperform
SeaStar MedicalOutperform Votes
1
100.00%
Underperform Votes
No Votes
Eucrates Biomedical AcquisitionN/AN/A

Summary

Eucrates Biomedical Acquisition beats SeaStar Medical on 5 of the 8 factors compared between the two stocks.

Get SeaStar Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for ICU and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ICU vs. The Competition

MetricSeaStar MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$13.21M$4.45B$5.40B$8.53B
Dividend YieldN/A42.37%5.15%4.14%
P/E Ratio-0.1536.56112.5515.07
Price / SalesN/A64.751,478.8293.55
Price / CashN/A49.2739.8334.04
Price / Book-0.484.214.645.01
Net Income-$26.23M$11.52M$119.13M$225.46M
7 Day Performance-15.13%1.05%0.78%0.37%
1 Month Performance-29.37%0.94%5.65%3.57%
1 Year Performance-86.36%39.40%36.90%29.42%

SeaStar Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ICU
SeaStar Medical
0.2427 of 5 stars
$3.03
-2.3%
N/A-86.3%$13.21MN/A-0.152News Coverage
EUCR
Eucrates Biomedical Acquisition
N/A$10.04
flat
N/A+0.0%$42.27MN/A0.004High Trading Volume
CLGN
CollPlant Biotechnologies
1.9752 of 5 stars
$3.90
-1.8%
$11.00
+182.1%
-43.5%$45.50M$689,000.00-2.5370Negative News
APYX
Apyx Medical
4.4991 of 5 stars
$1.27
+5.0%
$5.00
+293.7%
-49.1%$44.00M$49.03M-1.55270Upcoming Earnings
Positive News
Gap Up
CODX
Co-Diagnostics
3.2307 of 5 stars
$1.25
+1.6%
$1.50
+20.0%
+13.1%$39.89M$9.14M-0.99100Upcoming Earnings
Short Interest ↑
ALUR
Allurion Technologies
1.8825 of 5 stars
$0.75
-1.3%
$2.88
+281.2%
-83.9%$36.16M$47.59M-0.86501Gap Up
SURG
SurgePays
3.6214 of 5 stars
$1.77
+1.7%
$9.00
+408.5%
-64.2%$34.96M$137.14M19.6722News Coverage
DRIO
DarioHealth
2.1152 of 5 stars
$1.00
+3.1%
$4.00
+301.6%
-6.2%$29.81M$19.15M-0.84200Upcoming Earnings
STIM
Neuronetics
2.5974 of 5 stars
$0.99
flat
$4.67
+370.8%
-10.4%$29.70M$72.07M-0.88180Upcoming Earnings
News Coverage
FEMY
Femasys
3.4353 of 5 stars
$1.33
+4.7%
$10.67
+702.0%
-9.4%$29.57M$1.07M-1.6030Analyst Forecast
News Coverage
OM
Outset Medical
2.2769 of 5 stars
$0.55
+1.8%
$4.70
+748.7%
-83.8%$28.85M$130.38M-0.18520Upcoming Earnings

Related Companies and Tools


This page (NASDAQ:ICU) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners